Pergaris Alexandros, Levidou Georgia, Mandrakis Georgios, Christodoulou Maria-Ioanna, Karamouzis Michail V, Klijanienko Jerzy, Theocharis Stamatios
First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Department of Pathology, Paracelsus Medical University, 90419 Nuremberg, Germany.
Biomedicines. 2024 Aug 6;12(8):1772. doi: 10.3390/biomedicines12081772.
Uveal melanomas (UMs) represent rare malignant tumors associated with grim prognosis for the majority of patients. DAXX (Death Domain-Associated Protein), HJURP (Holliday Junction Recognition Protein) and CENPA (Centromere Protein A) proteins are implicated in epigenetic mechanisms, now in the spotlight of cancer research to better understand the molecular background of tumorigenesis. Herein, we investigated their expression in UM tissues using immunohistochemistry and explored possible correlations with a multitude of clinicopathological and survival parameters. The Cancer Genome Atlas Program (TCGA) was used for the investigation of their mRNA levels in UM cases. Nuclear DAXX expression correlated with an advanced T-stage ( = 0.004), while cytoplasmic expression marginally with decreased disease-free survival (DFS) ( = 0.084). HJURP nuclear positivity also correlated with advanced T-status ( = 0.054), chromosome 3 loss ( = 0.042) and increased tumor size ( = 0.03). More importantly, both nuclear and cytoplasmic HJURP immunopositivity correlated with decreased overall survival (OS) ( = 0.011 and 0.072, respectively) and worse DFS ( = 0.071 and 0.019, respectively). Lastly, nuclear CENPA overexpression was correlated with presence of irido-corneal angle involvement ( = 0.015) and loss of chromosome 3 ( = 0.041). Nuclear and cytoplasmic CENPA immunopositivity associated with decreased OS ( = 0.028) and DFS ( = 0.018), respectively. and mRNA overexpression exhibited strong association with tumor epithelioid histology and was linked to worse prognosis. Our results show the compounding role of DAXX, HJURP and CENPA in UM carcinogenesis, designating them as potential biomarkers for assessing prognosis and possible targets for novel therapeutic interventions.
葡萄膜黑色素瘤(UMs)是一种罕见的恶性肿瘤,大多数患者预后不佳。DAXX(死亡结构域相关蛋白)、HJURP(霍利迪连接点识别蛋白)和CENPA(着丝粒蛋白A)蛋白参与表观遗传机制,目前已成为癌症研究的焦点,有助于更好地理解肿瘤发生的分子背景。在此,我们采用免疫组织化学方法研究了它们在UM组织中的表达,并探讨了其与多种临床病理和生存参数之间可能存在的相关性。利用癌症基因组图谱计划(TCGA)研究了它们在UM病例中的mRNA水平。核DAXX表达与晚期T分期相关(P = 0.004),而胞质表达与无病生存期(DFS)轻度降低相关(P = 0.084)。HJURP核阳性也与晚期T状态相关(P = 0.054)、3号染色体缺失相关(P = 0.042)以及肿瘤大小增加相关(P = 0.03)。更重要的是,核和胞质HJURP免疫阳性均与总生存期(OS)降低相关(分别为P = 0.011和0.072)以及DFS较差相关(分别为P = 0.071和0.019)。最后,核CENPA过表达与虹膜角膜角受累相关(P = 0.015)以及3号染色体缺失相关(P = 0.041)。核和胞质CENPA免疫阳性分别与OS降低(P = 0.028)和DFS降低(P = 0.018)相关。DAXX和CENPA mRNA过表达与肿瘤上皮样组织学密切相关,并与更差的预后相关。我们的研究结果显示了DAXX、HJURP和CENPA在UM致癌过程中的复合作用,将它们指定为评估预后的潜在生物标志物以及新型治疗干预的可能靶点。